Blog Archive

BSCR Autumn Meeting 2020| Tissue engineering and regenerative medicine in cardiovascular disease

Start date: September 7, 2020 - End date: September 8, 2020

To include an Early Career Symposium on 7th September.

Location: Wills Memorial Building (TBC), Bristol, UK

Joint BAS/BSCR Late Spring Meeting 2020

Start date: June 1, 2020 - End date: June 2, 2020

Location: Manchester Central, Manchester, UK


Abstracts (Deadline 2nd March)

Preliminary Programme

Further Information on BCS website

Symposium Title: Novel Insights into Cardiovascular comorbidities

Monday 1st June 2020, 10.45-12.15

Chairs – Andy Sage, Rhian Touyz

Jose Fuster, CNIC Madrid – Clonal hematopoiesis – links to atherosclerotic disease

Ian Bruce, University of Manchester – Rheumatological diseases – a cardiovascular risk factor

Antony Vidal-Puig, University of Cambridge – Obesity and Adipose dysfunction in cardiovascular risk

Rhian Touyz, University of Glasgow – Diabetes, Hypertension, and Cardiovascular Disease: Clinical Insights and Vascular Mechanisms

Symposium Title: Neuroimmune Modulation of Cardiovascular Function

Monday 1st June 2020, 13.45-15.15

Chairs – Pasquale Maffia, Tomasz Guzik

Peder Olofsson – Neuronal control of inflammation and bioelectronic medicine

Prof Partha Dutta – Sympathetic Neuronal Activation Triggers Myeloid Progenitor Proliferation and Differentiation

Prof Daniela Carnevale – Neuroimmune Control of Cardiac and Vascular Remodelling in Hypertension

Dr Giuseppe D’Agostino – Control of Peripheral Metabolism via Genetic Modulation of Brain Circuits

Symposium Title: A decade of genome-wide association studies

Tuesday 2nd June 2020, 8.30-10.00

Chairs – Manuel Mayr, Sanjay Sinha

Jeanette Erdmann, Luebeck, Germany – What have we learnt for coronary artery disease?

Aroon Hingorani, UCL – Mendelian randomisation – causal analysis and drug development

Gerard Pasterkamp, Utrect, Netherlands – Fine-tuning the definition of the atherosclerotic plaque at risk, the value of bulk and single cell RNA sequencing of human plaques.

Hugh Watkins, Oxford – The impact of common variants on rare/inherited disease phenotypes

Other Sessions

Joint BCS/BAS/BSCR Young Investigator Prize

Deadlines to be announced shortly

Combined BCS/BAS/BSCR with the top 5 applications being selected for oral presentation on Tuesday lunchtime with a first prize of £1,000. Open to basic scientists who are no more than 5 years post-PhD and clinicians who have not attained consultant status. Application requires submission of a brief communication (1,000 words with up to 5 tables/figures). Please note that if your submission for the Young Investigator Prize is not shortlisted for presentation, it is not automatically entered as a standard poster abstract submission. To do this you will need to separately submit your abstract following the normal submission process and you are encouraged to do this – if your application for the Young Investigator Prize is subsequently shortlisted then you will have the option of withdrawing your standard poster abstract.

John French Lecture – tbc

Poster sessions

Hot Topics – Insights into novel techniques and approaches in cardiovascular science from leading practitioners

British Society for Heart Failure Autumn Meeting

Start date: November 28, 2019 - End date: November 29, 2019

Location: QEII Conference Centre, London, UK

Improving quality and reducing inequality in heart failure

Key dates

Young Investigators’ Award abstract submission deadline: 16 September
Early Bird rate registration deadline: 11 October

Visit the conference website at for details on abstract submission, registration and the scientific programme.

Frontiers in Cardiovascular Biomedicine

Start date: April 23, 2020 - End date: April 26, 2020

Location: Budapest, Hungary


Frontiers in Cardiovascular Biomedicine

6th Congress of the ESC Council on Basic Cardiovascular Science


Important Dates

25th October 2019: Abstract submission deadline

10th February 2020: Early registration fee deadline

16th March 2020: Late registration fee deadline


Please see the conference website for more details



Pharmacology 2019 | Detecting endothelial cell dysfunction towards the identification of novel therapeutic targets

Start date: December 15, 2019 - End date: December 17, 2019

Location: Edinburgh International Conference Centre, Scotland, UK

As in previous years, the BSCR is delighted to have been selected to organise a themed session at Pharmacology 2019.

Endothelial dysfunction is an early predictor of vascular disease and associated risk factors and co-morbidities, including hypertension, diabetes, dementia and aging. It is hallmarked by an imbalance in the release of mediators, due to a number of mechanisms including oxidative stress and elevated levels of reactive oxygen species. There is a drive for the early detection of endothelial dysfunction to enable targeted delivery of novel therapies that will prevent or slow disease progression. This symposium will discuss efforts to identify novel targets and emerging pharmacological intervention strategies, towards treatment and the restoration of vascular health and function

Session Details:  
Sunday 15th December (11.45 - 13.30)

Dr May Azzawi, Manchester Metropolitan University, UK 
Dr Stephen White, Manchester Metropolitan University, UK

The role of Cystathionine γ Lyase Sulfhydrates in the preservation of endothelial cell function
Dr Iris Bibli, Goethe University, Germany

Cerebrovascular protective effects of the GH/GF-1 system in ageing
Dr Anna Csiszar, University of Oklahoma Health Sciences Center, USA

Endothelial derived C-type Natriuretic peptide in vascular homeostasis
Professor Adrian Hobbs, Queen Mary University of London, UK

Resveratrol potentiates vasorelaxation, via interaction with multiple dilator pathways
Dr May Azzawi, Manchester Metropolitan University, UK

Investigating BACE1 inhibition as a novel therapeutic approach for endothelial dysfunction associated with type 2 diabetes
Dr Paul Meakin, University of Leeds, UK

Conference Registration & Abstract Submission

Registration is now open and discounted for BSCR members. BSCR members are encouraged to submit abstracts for the main meeting (deadline 13th September 2019). Please visit the British Pharmacological Society meeting website for further details:

BSCR Autumn Meeting | Heart Failure – new therapeutic strategies

Start date: September 9, 2019 - End date: September 10, 2019

Location: Emmanuel College, University of Cambridge

Scientific Programme

The full programme can be found here. Highlights include:

  • Scientific Session: Pathobiology and management of heart failure
  • Scientific Session: Cell Therapy and Tissue Engineering for Heart Failure
  • Scientific Session: The Academia-Industry Interface in Heart Failure
  • Bernard and Joan Marshall Young Investigator Award presentations
  • Bernard and Joan Marshall Distinguished Lecture (Professor Joseph Wu, Stanford University; Cardiac repair and regeneration)
  • BSCR Keynote Lecture (Professor Ajay Shah, King’s College London; ROS, NO and heart failure)
  • Poster session and Early Career Symposium

Submit an abstract

The abstract submission system is now closed (deadline Monday 22nd July)

The top 6 abstracts will be selected for oral presentation over the two days of the Meeting. All other accepted abstracts will be presented as posters at the poster session on Monday evening (posters will be available to view throughout the meeting). Notification of the outcome of your submission will be sent via e-mail in August 2019.

Register for the meeting

Standard registration fees (after July 22nd 2019)

  • BSCR student member (£35)
  • BSCR ordinary member (£80)
  • Non-member (£150)
  • Commercial (£150)
  • Invited speaker (free)

Please complete the registration form to attend the main meeting and ECR symposium (free). The conference dinner, which will take place at Emmanuel College, can also be booked here along with accommodation. Registration deadline: Monday 2nd September 2019

Apply here for membership to take advantage of reduced registration rates

Accommodation at Emmanuel College

The following
accommodation is available on-site at Emmanuel College:

  • Standard single room (£45) – note these rooms do not have en suite facilities
  • Single room with en-suite (£65)
  • Twin room with en-suite (£95)

Accommodation can be booked as part of the registration

More about Emmanuel College accommodation can be found here

Getting to Emmanuel College

The easiest way to travel to the conference is by rail. Emmanuel College is located within walking distance from Cambridge Station (~20 min walk), or alternatively, a taxi rank can be found just outside the station. A map of the college can be found here

Parking: There are no parking facilities available on-site. Delegates are strongly advised to travel by other means. For those delegates who need to travel by car, the nearest parking facility is located at the Queen Anne Terrace Car Park, Parkers Piece (CB1 1ND).

Student Travel Grants

The BSCR will consider awarding travel grants of up to £200 to bona fide students who are BSCR members towards the cost of attending this meeting. Awards are made at the discretion of the BSCR Treasurer, whose decision will be final. The aim of the scheme is to encourage PhD and DPhil students to attend and contribute to the meeting


  • The applicant must be registered for a PhD or DPhil in an institution in the United Kingdom.
  • The applicant must be a member of the British Society for Cardiovascular Research at the time of application.
  • The applicant must be the presenting author of an abstract accepted for communication at the meeting.
  • Students may only make one application per calendar year.
  • The applicant must state the mode of travel (e.g. rail, car, etc.) and claims must be based on the most economical mode and class of travel up to a maximum of £150.
  • Hotel accommodation must be no more than 3* or equivalent.
  • The cost of meals may not be included in the claim

Apply for a travel grant here

Deadline for application: Monday 26th August


The BSCR is grateful to the following companies for sponsoring the meeting:

Physiology 2019 Satellite Symposium | Cellular Mechanisms of anti-cancer induced cardiotoxicity

Date: July 7, 2019

Location: Aberdeen Exhibition & Conference Centre, UK


Deadline for abstract submission: 15th April 2019

For more details on the symposium programme and abstract submission please click here



Susan Currie (University of Strathclyde, UK)

Margaret Cunningham (University of Strathclyde, UK)

Heart Rhythm Congress 2019

Start date: October 6, 2019 - End date: October 9, 2019

Location: The ICC, Birmingham, UK

BSCR Session | Tuesday 8 October, 08:30-10:00

Bench to Bedside: scientific frontiers of electrophysiology

Preliminary programme
What has basic science ever done for me, a clinician?
Matt Daniels, Oxford, UK

Why do athletes get arrhythmias, and what can we do (apart from burn them)?
Luis Mont, Barcelona, Spain

Data, AI and the android electrophysiologist: Machine learning for you, your patients and your job
Blanca Rodriguez, Oxford, UK


The organisers invite submission of abstracts from BSCR members to present at this session

The deadline for submission is 31st May 2019.

If your abstract is selected, the presenting author will be eligible to register for the congress at the abstract presenter rate. Successful abstracts will be published in peer reviewed EP Europace journal. For details on submission please go to the conference abstract page

For more details on the conference and for the full programme please click here

ESC Myocardial Function & Cellular Biology of the Heart Meeting

Start date: May 9, 2019 - End date: May 11, 2019

Location: Naples, Italy

Biennial Meeting
Topic(s): Cardiac Biology and Physiology; Myocardial Disease

The joint meeting of the ESC Working Groups on Myocardial Function and Cellular Biology of the Heart has become a traditional meeting held every two years and presenting the cutting-edge of scientific outcomes in dedicated fields. It offers the opportunity to network and allows scientific exchanges in a friendly and relaxed atmosphere, between early career researchers and outstanding international speakers.

Deadline to submit abstract: 1 April 2019

For more information please click here

Dyslipidaemias | HEART UK 33rd Annual Medical & Scientific Conference

Start date: July 3, 2019 - End date: July 5, 2019

Location: Warwick Arts Centre, University of Warwick, Coventry, CV4 7AL

heart uk cholesterol charity


A line-up of internationally recognised speakers including:

  • Professor Stephen O'Rahilly (University of Cambridge)
  • Dr David Unwin (Norwood Surgery, Southport)
  • Ms Michaela Nuttall (Director for Smart Health Solutions)
  • Professor Charalambos Antoniades (University of Oxford)
  • Dr Maggie Williams (Bristol Genetics Lab)
  • Dr Jen Unwin (Consultant Clinical Health Pyschologist)

Full programme is available here

Abstract Submission

Abstract submissions are invited by healthcare professionals on any topic relating to cholesterol and related conditions, including cardiovascular disease, diabetes, atherosclerosis

Submit an Abstract

Abstract submission:  23:59 hrs - Monday 11 March  

Abstract authors notified of outcome:  Latest Friday 5 April

Key deadline dates 2019:

Rianna Wingett award deadline:  23:59 hrs – Monday 8 April

Early bird registration deadline23:59 hrs – Monday 13 May

Deadline for registration refunds or cancellations (non negotiable):  23:59 hrs – Monday 10 June


A limited number of Travel Grants are available

Apply for a Travel Grant

Travel grant deadline23:59 hrs – Monday 8 April

Travel grant applicants notified of outcome: Monday 15 April


Who should attend?
includes - Consultants, SpRs, Chemical Pathologists, Clinical Lipidologists, Geneticists, Cardiologists, Vascular Surgeons, Cardiovascular Radiologists, General Practitioners, GPs with Specialist Interest in CVD, Physicians, Diabetologists, Scientists and researchers in cardiovascular diseases

Specialist FH nurses, Dietitians, Nutritionists, Ancillary health professionals, Caring Professionals, Community Pharmacists, Directors of Public Health, Healthcare Commissioners